Health Science Startups Toronto: Difference between revisions

From Federal Burro of Information
Jump to navigationJump to search
(Created page with " {| class="wikitable" ! Startup !! Description !! Founded !! Funding |- | BenchSci || Uses AI to empower scientists to run more successful experiments to accelerate drug discovery || 2012 || Over $45 million |- | ACTO || An omnichannel education platform for life sciences companies || 2014 || Over $11 million |- | Nanology Labs || A pharmaceutical company that harnesses advanced nanotechnology to detect and treat cancers at the early stages || 2016 || Over $3 million |-...")
 
No edit summary
Line 1: Line 1:




{| class="wikitable"
{| class="wikitable sortable"
! Startup !! Description !! Founded !! Funding
! Startup !! Description !! Founded !! Funding
|-
|-

Revision as of 03:19, 9 August 2023


Startup Description Founded Funding
BenchSci Uses AI to empower scientists to run more successful experiments to accelerate drug discovery 2012 Over $45 million
ACTO An omnichannel education platform for life sciences companies 2014 Over $11 million
Nanology Labs A pharmaceutical company that harnesses advanced nanotechnology to detect and treat cancers at the early stages 2016 Over $3 million
Geneseeq Uses NGS technologies to help physicians make meaningful decisions for cancer treatment 2012 Over $100 million
Meta An intelligent system that can read, understand, and reason over scientific and technical literature. Acquired by the Chan Zuckerberg Initiative in 2017 N/A N/A
NEXT Integrative Minds Life Sciences Ltd. A personal performance improvement system that works by training users to self-direct their neuroplasticity 2017 Over $2 million
Vasomune Inc A biotechnology company, developing therapies for blood vessel diseases – vascular dysfunction and destabilization 2010 Over $10 million
GeneYouIn A Canadian personalized medicine company, has developed a genome analytics and reporting platform called Pillcheck 2013 Over $2 million
Shift Health A healthcare strategy consultancy for Healthcare & Life Sciences Leaders 2014 Over $5 million
Phycus Biotechnologies Provides a bio-conversion platform intended to convert CO2 and diverting GHG emissions from large scale emitters 2016 Over $2 million